Ad is loading...
NUWE
Price
$1.80
Change
+$0.02 (+1.12%)
Updated
Nov 15 closing price
TLTFF
Price
$0.21
Change
+$0.01 (+5.00%)
Updated
Nov 15 closing price
Ad is loading...

NUWE vs TLTFF

Header iconNUWE vs TLTFF Comparison
Open Charts NUWE vs TLTFFBanner chart's image
Nuwellis
Price$1.80
Change+$0.02 (+1.12%)
Volume$2.82M
CapitalizationN/A
Theralase Technologies
Price$0.21
Change+$0.01 (+5.00%)
Volume$18.86K
CapitalizationN/A
NUWE vs TLTFF Comparison Chart
Loading...
NUWE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
NUWE vs. TLTFF commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NUWE is a StrongSell and TLTFF is a Hold.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (NUWE: $1.80 vs. TLTFF: $0.21)
Brand notoriety: NUWE and TLTFF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NUWE: 79% vs. TLTFF: 24%
Market capitalization -- NUWE: $2.42M vs. TLTFF: $47.58M
NUWE [@Medical Specialties] is valued at $2.42M. TLTFF’s [@Medical Specialties] market capitalization is $47.58M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NUWE’s FA Score shows that 0 FA rating(s) are green whileTLTFF’s FA Score has 0 green FA rating(s).

  • NUWE’s FA Score: 0 green, 5 red.
  • TLTFF’s FA Score: 0 green, 5 red.
According to our system of comparison, NUWE is a better buy in the long-term than TLTFF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NUWE’s TA Score shows that 6 TA indicator(s) are bullish.

  • NUWE’s TA Score: 6 bullish, 4 bearish.

Price Growth

NUWE (@Medical Specialties) experienced а -0.55% price change this week, while TLTFF (@Medical Specialties) price change was -1.44% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Reported Earning Dates

NUWE is expected to report earnings on May 09, 2023.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLTFF($47.6M) has a higher market cap than NUWE($2.42M). TLTFF YTD gains are higher at: 51.471 vs. NUWE (-91.147). TLTFF has higher annual earnings (EBITDA): -4.59M vs. NUWE (-16.36M). NUWE has more cash in the bank: 3.8M vs. TLTFF (366K). TLTFF has less debt than NUWE: TLTFF (453K) vs NUWE (760K). NUWE has higher revenues than TLTFF: NUWE (8.86M) vs TLTFF (1.13M).
NUWETLTFFNUWE / TLTFF
Capitalization2.42M47.6M5%
EBITDA-16.36M-4.59M356%
Gain YTD-91.14751.471-177%
P/E Ratio0.02N/A-
Revenue8.86M1.13M782%
Total Cash3.8M366K1,038%
Total Debt760K453K168%
FUNDAMENTALS RATINGS
NUWE vs TLTFF: Fundamental Ratings
NUWE
TLTFF
OUTLOOK RATING
1..100
4950
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
70
Overvalued
PROFIT vs RISK RATING
1..100
10085
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
6436
P/E GROWTH RATING
1..100
88100
SEASONALITY SCORE
1..100
5095

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NUWE's Valuation (41) in the Medical Specialties industry is in the same range as TLTFF (70) in the null industry. This means that NUWE’s stock grew similarly to TLTFF’s over the last 12 months.

TLTFF's Profit vs Risk Rating (85) in the null industry is in the same range as NUWE (100) in the Medical Specialties industry. This means that TLTFF’s stock grew similarly to NUWE’s over the last 12 months.

TLTFF's SMR Rating (99) in the null industry is in the same range as NUWE (100) in the Medical Specialties industry. This means that TLTFF’s stock grew similarly to NUWE’s over the last 12 months.

TLTFF's Price Growth Rating (36) in the null industry is in the same range as NUWE (64) in the Medical Specialties industry. This means that TLTFF’s stock grew similarly to NUWE’s over the last 12 months.

NUWE's P/E Growth Rating (88) in the Medical Specialties industry is in the same range as TLTFF (100) in the null industry. This means that NUWE’s stock grew similarly to TLTFF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NUWE
RSI
ODDS (%)
Bearish Trend 3 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 7 days ago
83%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
81%
View a ticker or compare two or three
Ad is loading...
NUWE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TCBP0.660.01
+2.03%
TC BioPharm (Holdings) plc
FRT113.540.17
+0.15%
Federal Realty Investment Trust
UCTT33.97-1.13
-3.22%
Ultra Clean Holdings
YMAB11.14-0.45
-3.88%
Y-mAbs Therapeutics
ORMP2.23-0.11
-4.50%
Oramed Pharmaceuticals

NUWE and

Correlation & Price change

A.I.dvisor tells us that NUWE and CORBF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NUWE and CORBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUWE
1D Price
Change %
NUWE100%
+1.12%
CORBF - NUWE
24%
Poorly correlated
+4.00%
PRE - NUWE
24%
Poorly correlated
-6.44%
BNR - NUWE
23%
Poorly correlated
+1.35%
BLOZF - NUWE
22%
Poorly correlated
+8.08%
PSNL - NUWE
22%
Poorly correlated
-9.53%
More

TLTFF and

Correlation & Price change

A.I.dvisor tells us that TLTFF and ZTEK have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLTFF and ZTEK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLTFF
1D Price
Change %
TLTFF100%
+0.61%
ZTEK - TLTFF
28%
Poorly correlated
+29.96%
NUWE - TLTFF
21%
Poorly correlated
+1.12%
NEOG - TLTFF
21%
Poorly correlated
-0.27%
UEEC - TLTFF
20%
Poorly correlated
N/A
VPTDF - TLTFF
13%
Poorly correlated
+2.99%
More